Macrogenics reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US $ 28458M 2671M
AstraZeneca AZN:LN 24601M 6727M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Cerulean Pharma CERU:US $ 0 0
Daiichi Sankyo 4568:JP Y 163347M 33148M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 14736.6M 1463M
Epizyme EPZM:US $ 231.2M 691K
Genmab GEN:DC 384M 58M
Immunogen IMGN:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 301.38M 59.58M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Puma Biotechnology PBYI:US $ 68.71M 7.64M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Seattle Genetics SGEN:US $ 0M 0M
Xencor XNCR:US $ 0M 0M